Engineered immune cells take on autoimmune disease
Disease control
Ongoing
This early-stage trial is testing a new treatment for people with severe lupus or scleroderma that hasn't responded to standard therapies. The treatment involves taking a patient's own immune cells, modifying them to target and destroy faulty immune cells, and giving them back al…
Phase: PHASE1 • Sponsor: Synthekine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC